Jan. 21, 2022
by Andrii Buvailo
Biopharma insight
In November 2021, the parent company of Google, Alphabet, Inc., announced the launch of a new commercial subsidiary in the …
Oct. 22, 2019
by Katherine (Tori) Lutz
Biopharma insight
Artificial intelligence continues to expand into more aspects of human life on a weekly basis. The field is no longer …
July 24, 2019
by Jacob LaPorte
Biopharma insight
In a seminal work published by McKinsey & Company – The Granularity of Growth, a detailed study of the performance …
May 11, 2020
by Andrii Buvailo
Interview
Canada has a firm place in the global life sciences ecosystem, being the tenth largest market for pharmaceutical sales, and …
July 25, 2019
by Tudor Oprea
Biopharma insight
About one in three human proteins is understudied. Even when quantifying data is available from multiple sources, "dark" genes and proteins …
March 18, 2020
by Irina Bilous
Biopharma insight
The microbiome is implicated in a number of metabolic pathways and communicates closely with our body in health and diseases. …
May 15, 2023
by Irina Bilous
Biopharma insight
The landscape of biotechnology is rapidly evolving, with coding and machine learning becoming integral to the innovative processes. A recent …
Jan. 24, 2022
by Chris De Savi
Biopharma insight
Antimicrobial resistance (AMR) poses a major threat to human health. There were an estimated 4.95M deaths associated with bacterial AMR …
Feb. 21, 2020
by Cathal Strain
Biopharma insight
Pharmaceutical manufacturers find themselves at a critical juncture. In the past 30 years, pharma has seen some significant shifts. Consider …
June 30, 2016
by Andrii Buvailo
Biopharma insight
Increasing the success rate of high-throughput screening (HTS) and the quality of the resulting hits as well as developability of …
April 25, 2022
by Andrii Buvailo
Biopharma insight
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
May 27, 2019
by David Shlaes
Biopharma insight
Over the past decade, pull incentives as a solution to the broken antibiotic market have been proposed to entice companies …